Managing Hepatocellular Carcinoma and its Recurrence Post Liver Transplant: Mt. Sinai Hospital ONLY

February 21, 2025

At the Hospital or Via Zoom

Target Audience

All pharmacists

Learning Objectives

 

At the completion of this activity, the participant will be able to:

Identify risk factors for recurrent hepatocellular carcinoma (HCC) post liver transplantation
List post-transplant screening methods to assess for HCC recurrence
Compare strategies to manage immunosuppressive regimens after liver transplant in patients with recurrent hepatocellular carcinoma
Describe the role of systemic therapies, immunotherapy, and adjuvant chemotherapy to prevent disease recurrence

 

 

 

 

 

 

 

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
02/19/2025
Course expires: 
11/21/2025
Event starts: 
02/21/2025 - 1:00pm EST
Event ends: 
02/21/2025 - 2:00pm EST
Cost:
$0.00
Add to calendar: 
Rating: 
0
Zoom or Hospital
NY 12866
United States

 

 

      • Elise Gerdes, PharmD – PGY2 Solid Organ Transplant Pharmacy Resident

     

      • Elise Gerdes, PharmD is currently a PGY2 Solid Organ Transplant Pharmacy Resident at the Mount Sinai Hospital in NY, NY. She earned her PharmD degree from the Rutgers University Ernest Mario School of Pharmacy and completed her PGY1 training that Hackensack University Medical Center in Hackensack, NJ.  Upon completion of her PGY2, she plans to pursue her clinical practice in the field of kidney transplantation.  

ACPE UAN #  0042-0000-25-009-L01-P

  
  
  

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.